A Double Blind Placebo Controlled Crossover Pilot Trial of Sativex With Open Label Extension for Treatment of Chemotherapy Induced Neuropathic Pain.
Phase of Trial: Phase III
Latest Information Update: 15 May 2015
At a glance
- Drugs Nabiximols (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 01 Nov 2012 Planned end date changed from 1 Jun 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 01 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Jan 2011 Actual initiation date changed from 1 Jun 2009 to 1 Jun 2010 as reported by ClinicalTrials.gov.